Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment
- 1 February 2018
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 63, 1-18
Abstract
No abstract availableKeywords
Funding Information
- Italian Association for Cancer Research (AIRC- IG15895 to DN)
This publication has 252 references indexed in Scilit:
- Trans-3,4,5,4′-tetramethoxystilbene, a resveratrol analog, potently inhibits angiogenesis in vitro and in vivoActa Pharmacologica Sinica, 2013
- Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFκB-cMyc-p21 pathwayFood Chemistry, 2012
- Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1α pathwayBiochemical and Biophysical Research Communications, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Structure−Function Relationships of Inhibition of Human Cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 Flavonoid DerivativesChemical Research in Toxicology, 2010
- Differential regulation of the dioxin-induced Cyp1a1 and Cyp1b1 genes in mouse hepatoma and fibroblast cell linesToxicology Letters, 2010
- Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon–DNA adduct levels in human prostateThe Prostate, 2009
- The Search for Endogenous Activators of the Aryl Hydrocarbon ReceptorChemical Research in Toxicology, 2007
- Potential Mechanisms of Estrogen Quinone CarcinogenesisChemical Research in Toxicology, 2007
- Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug developmentBioorganic & Medicinal Chemistry, 2007